164 related articles for article (PubMed ID: 2831436)
1. Human colon cell line HT-29: characterisation of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone.
Brehier A; Thomasset M
J Steroid Biochem; 1988 Feb; 29(2):265-70. PubMed ID: 2831436
[TBL] [Abstract][Full Text] [Related]
2. Receptors for and bioresponses to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29).
Harper KD; Iozzo RV; Haddad JG
Metabolism; 1989 Nov; 38(11):1062-9. PubMed ID: 2554092
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation.
Giuliano AR; Franceschi RT; Wood RJ
Arch Biochem Biophys; 1991 Mar; 285(2):261-9. PubMed ID: 1654769
[TBL] [Abstract][Full Text] [Related]
4. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
Zhao X; Feldman D
Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colonic carcinoma cells and on the reversal of the differentiated phenotype.
Tanaka Y; Bush KK; Eguchi T; Ikekawa N; Taguchi T; Kobayashi Y; Higgins PJ
Arch Biochem Biophys; 1990 Feb; 276(2):415-23. PubMed ID: 2306105
[TBL] [Abstract][Full Text] [Related]
6. Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice.
Merke J; Schwittay D; Fürstenberger G; Gross M; Marks F; Ritz E
Calcif Tissue Int; 1985 May; 37(3):257-67. PubMed ID: 2990643
[TBL] [Abstract][Full Text] [Related]
7. Association of 1,25-dihydroxyvitamin D3 with cultured 3T6 mouse fibroblasts. Cellular uptake and receptor-mediated migration to the nucleus.
Pike JW; Haussler MR
J Biol Chem; 1983 Jul; 258(14):8554-60. PubMed ID: 6305993
[TBL] [Abstract][Full Text] [Related]
8. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells.
Costa EM; Blau HM; Feldman D
Endocrinology; 1986 Nov; 119(5):2214-20. PubMed ID: 3021437
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
[TBL] [Abstract][Full Text] [Related]
12. Specific cytosol binding proteins for 25(OH)D3 and 1.25(OH)2D3 in human breast cancers.
Nakata M; Tsuboi S; Takenaka M; Konishi Y; Kawashima R; Tomita M; Nakagawa T; Iwamura N; Fujita T
Endocrinol Jpn; 1981 Dec; 28(6):741-6. PubMed ID: 6286292
[TBL] [Abstract][Full Text] [Related]
13. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.
Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P
Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
[TBL] [Abstract][Full Text] [Related]
16. The ovary: a target organ for 1,25-dihydroxyvitamin D3.
Dokoh S; Donaldson CA; Marion SL; Pike JW; Haussler MR
Endocrinology; 1983 Jan; 112(1):200-6. PubMed ID: 6291916
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 1,25-dihydroxyvitamin D3 receptors and in vivo targeting of [3H]-1,25(OH)2D3 in the sheep placenta.
Ross R; Florer J; Halbert K; McIntyre L
Placenta; 1989; 10(6):553-67. PubMed ID: 2558376
[TBL] [Abstract][Full Text] [Related]
18. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
Kuribayashi T; Tanaka H; Abe E; Suda T
Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
20. A 1,25-dihydroxyvitamin D3 receptor-like protein in mammalian and avian liver nuclei.
Duncan WE; Whitehead D; Wray HL
Endocrinology; 1988 Jun; 122(6):2584-9. PubMed ID: 2836167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]